{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:42:05Z","timestamp":1781325725331,"version":"3.54.1"},"reference-count":36,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2015,10,23]]},"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown aetiology that predominantly affects infants and young children. We hypothesise that cyclosporin A (CsA) may be effective in treating KD by regulating the Ca\n                      <jats:sup>2+<\/jats:sup>\n                      \/NFAT signalling pathway. This trial compares the current standard therapy of intravenous immunoglobulin (IVIG) and the combined IVIG+CsA therapy in paediatric patients with severe KD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This trial is a phase III, multicentre, randomised, open-label, blinded-end point trial that evaluates the efficacy and safety of IVIG+CsA therapy. Patients with severe KD who satisfy the eligibility criteria are randomised (1:1) to receive either CsA (5\u2005mg\/kg\/day for 5\u2005days; Neoral) plus high-dose IVIG (2\u2005g\/kg for 24\u2005h and aspirin 30\u2005mg\/kg\/day), or high-dose IVIG alone (2\u2005g\/kg for 24\u2005h and aspirin 30\u2005mg\/kg\/day). The primary end point is the frequency of occurrence of coronary artery abnormalities during the trial period. An independent end point review committee will be in charge of the trial assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The protocol was approved by the Institutional Review Board of each institution. The trial was notified and registered at the Pharmaceutical and Medical Devices Agency, in Japan. The trial is currently on-going and is scheduled to finish in April 2017. The findings will be disseminated through peer-reviewed publications and conference presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>JMA-IIA00174; Pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2015-009562","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T21:54:11Z","timestamp":1449006851000},"page":"e009562","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)"],"prefix":"10.1136","volume":"5","author":[{"given":"Reiko","family":"Aoyagi","sequence":"first","affiliation":[{"name":"Clinical Research Centre, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[{"name":"Clinical Research Centre, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Onouchi","sequence":"additional","affiliation":[{"name":"Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Ebata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-9045","authenticated-orcid":false,"given":"Kengo","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Clinical Research Centre, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Terauchi","sequence":"additional","affiliation":[{"name":"Clinical Research Centre, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Terai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"Clinical Research Centre, Chiba University Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"2025121604591606000_5.12.e009562.1","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"key":"2025121604591606000_5.12.e009562.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16814-1"},{"key":"2025121604591606000_5.12.e009562.3","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20090180"},{"key":"2025121604591606000_5.12.e009562.4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease","volume":"324","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"2025121604591606000_5.12.e009562.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608073150601"},{"key":"2025121604591606000_5.12.e009562.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106063242305"},{"key":"2025121604591606000_5.12.e009562.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61930-2"},{"key":"2025121604591606000_5.12.e009562.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.12.021"},{"key":"2025121604591606000_5.12.e009562.9","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000019733.56553.D8"},{"key":"2025121604591606000_5.12.e009562.10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2007.59"},{"key":"2025121604591606000_5.12.e009562.11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq176"},{"key":"2025121604591606000_5.12.e009562.12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/tpj.2011.45","article-title":"ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease","volume":"13","author":"Onouchi","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"2025121604591606000_5.12.e009562.13","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318220c3cf"},{"key":"2025121604591606000_5.12.e009562.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200x.2005.02033.x"},{"key":"2025121604591606000_5.12.e009562.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.592865"},{"key":"2025121604591606000_5.12.e009562.16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cpt1974155443","article-title":"Minimization: a new method of assigning patients to treatment and control groups","volume":"15","author":"Taves","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"2025121604591606000_5.12.e009562.17","doi-asserted-by":"publisher","DOI":"10.2307\/2529712"},{"key":"2025121604591606000_5.12.e009562.18","unstructured":"Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan: Ministry of Health and Welfare, 1984 (in Japanese)."},{"key":"2025121604591606000_5.12.e009562.19","doi-asserted-by":"crossref","unstructured":"Agresti A . Categorical data analysis. 3rd edn. Wiley, 2012.","DOI":"10.1007\/978-3-642-04898-2_161"},{"key":"2025121604591606000_5.12.e009562.20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","article-title":"Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan","volume":"27","author":"Uehara","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"2025121604591606000_5.12.e009562.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-002-0216-2"},{"key":"2025121604591606000_5.12.e009562.22","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199812000-00009"},{"key":"2025121604591606000_5.12.e009562.23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200x.2001.01373.x"},{"key":"2025121604591606000_5.12.e009562.24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00246-014-1016-1","article-title":"Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database","volume":"36","author":"Moffett","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"2025121604591606000_5.12.e009562.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.028423"},{"key":"2025121604591606000_5.12.e009562.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80689-8"},{"key":"2025121604591606000_5.12.e009562.27","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000202067.50975.90"},{"key":"2025121604591606000_5.12.e009562.28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.6.e65"},{"key":"2025121604591606000_5.12.e009562.29","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3345\/kjp.2008.51.12.1320","article-title":"Epidemiologic study of Kawasaki disease in 6 months old and younger infants","volume":"51","author":"Park","year":"2008","journal-title":"Korean J Pediatr"},{"key":"2025121604591606000_5.12.e009562.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1996.tb14201.x"},{"key":"2025121604591606000_5.12.e009562.31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3345\/kjp.2012.55.6.202","article-title":"Epidemiology of Kawasaki disease in infants 3 months of age and younger","volume":"55","author":"Lee","year":"2012","journal-title":"Korean J Pediatr."},{"key":"2025121604591606000_5.12.e009562.32","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000145143.19711.78"},{"key":"2025121604591606000_5.12.e009562.33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.104.1.e5"},{"key":"2025121604591606000_5.12.e009562.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01655-1"},{"key":"2025121604591606000_5.12.e009562.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62298-9"},{"key":"2025121604591606000_5.12.e009562.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061235"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2015-009562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:59:25Z","timestamp":1765889965000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2015-009562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,1]]},"published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1136\/bmjopen-2015-009562"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2015-009562","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}